| Factor Information | |
|---|---|
| Data ID | 1892 |
| Factor | Procedure-type categories 4 |
| Description | During the study period, there was an increase in number of procedures per year (P < .001) and a decrease in frequency of adverse events (P = .01). Procedure-type categories 4 had increased risk of adverse events when compared with category 2, with odds ratios of 2.3 ( (95% CI: 1.4–3.6) for category 4. |
| Biomarker | NA |
| Classification | A9 (clinical factor - risk category) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | with transcatheter interventions in congenital heart disease and examine predictors for adverse events. |
| p Value | 0.001 |
| OR | 2.3 |
| Conclusion | We found an increase in number of procedures over time and a decrease in frequency of adverse events. Higher procedure-type risk categories were associated with increased risk of adverse events. |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 562 |
| CHD Type | isolated CHD |
| CHD Subtype | PDA/ASD/PV/PAS/TGA/CoA/PFO/AVS/PA/TOF/DORV/UVH/VSD/other |
| Reference | |
|---|---|
| PMID | 25196278 |
| Year | 2015 |
| Title | Adverse events in transcatheter interventions for congenital heart disease: a population-based long-term study |
| Sample | ||
|---|---|---|
| Population | All | |
| Source | N/A | |
| Region | Aarhus, Denmark | |
| Method | N/A | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | Transcatheter Interventions | |
| Group | Procedure-type categories 4(Treatment) | Procedure-type categories 2(Control) |
| Number | N/A | 296 |
| Age | Age, median (IQR): 5.3 (1.1–22.3)(patients with 4 procedures) | Age, median (IQR): 5.3 (1.1–22.3)(patients with 2 procedures) |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | N/A | N/A |
